Top Markets
Coin of the day
NanoVibronix, Inc. NanoVibronix, Inc.

NanoVibronix, Inc.

NAOV
Rankning i aktier #37687
NanoVibronix, Inc., operating through its subsidiary NanoVibronix Ltd.,... NanoVibronix, Inc., operating through its subsidiary NanoVibronix Ltd., develops and commercializes innovative, non-invasive devices that stimulate biological responses for therapeutic purposes. Their core focus areas include mitigating biofilm formation, accelerating wound repair, and alleviating pain. Key among their product line is UroShield, an ultrasound-based solution engineered to deter bacterial colonization and biofilm development in urinary catheters, thereby boosting antibiotic efficacy and reducing associated patient discomfort. They also offer PainShield and WoundShield, both patch-based therapeutic ultrasound technologies. PainShield targets relief from pain, muscle spasms, and joint contractures, while WoundShield is designed to foster tissue regeneration and promote healing in wounds. The company distributes these products directly to consumers and via extensive distributor networks spanning the United States, Israel, Europe, India, and numerous other international regions. Founded in 2003, NanoVibronix, Inc. maintains its corporate headquarters in Elmsford, New York.
Aktiekurs
$1.90
Senast synkroniserad: 2026-03-11
Marknadsvärde
$1.51M
Förändring (1 dag)
-41.54%
Förändring (1 år)
-67.58%
Land
US
Handel NanoVibronix, Inc. (NAOV)

Kategori

P/B-tal för NanoVibronix, Inc. (NAOV)
P/B-tal per 2026 TTM: 0
Enligt NanoVibronix, Inc. senaste finansiella rapporter och aktiekurs är det aktuella P/B-talet (TTM) 0. I slutet av 2026 hade företaget ett P/B-tal på 0.
Historik för P/B-tal för NanoVibronix, Inc. från 2026 till 2026
P/B-tal vid årets slut
År P/B-tal Ändra
Inte tillräckligt med data för de angivna datumen.
P/B-tal för liknande företag eller konkurrenter
Företag P/B-tal Skillnad i P/B-tal Land
3.6048 -
US
5.423 -
US
2.0146 -
IE
2.6697 -
US
4.8038 -
US